Heart Attack Diagnostics Market Analysis by Test type (Electrocardiogram, Blood Tests (Troponin, CK-MB), Echocardiogram), by Region (U.S., Canada, UK, Germany, China, India, Brazil, Mexico, South Africa, Middle East), and Segment Forecasts to 2024

Table of Content

Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
                     4.1. Market Segmentation &Scopes
                     4.2. Heart Attack Diagnostics: Market dynamics
                        4.2.1. Market Driver Analysis
                        4.2.2. Market Restraint Analysis
                     4.3. Key opportunities prioritized
                     4.4. Heart Attack Diagnostics - SWOT Analysis, By Factor (Political &Legal, Economic and Technological)
                     4.5. Industry Analysis - Porter’s
                     4.6. Heart Attack Diagnostics Market: Company Market Share Analysis, 2015
Chapter 5. Market Categorization 1: Heart Attack Diagnostics Test Type Estimates & Trend Analysis
                     5.1. Heart Attack Diagnostics Market: Test Type Movement Analysis
                     5.2. Electrocardiogram (ECG or EKG)
                        5.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                     5.3. Blood tests
                        5.3.1. Troponin
                              5.3.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                        5.3.2. CK-MB
                              5.3.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
                     5.4. Others
                        5.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 6. Heart Attack Diagnostics: Regional Estimates & Trend Analysis, by Test Type
                     6.1. Heart Attack Diagnostics Market Share (%) Analysis, by Region, 2016 & 2024
                     6.2. North America
                        6.2.1. The U.S.
                              6.2.1.1. U.S. heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                        6.2.2. Canada
                              6.2.2.1. Canada heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                     6.3. Europe
                        6.3.1. Germany
                              6.3.1.1. Germany heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                        6.3.2. UK
                              6.3.2.1. UK heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                     6.4. Asia Pacific
                        6.4.1. China
                              6.4.1.1. China heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                        6.4.2. India
                              6.4.2.1. India heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                     6.5. Latin America
                        6.5.1. Brazil
                              6.5.1.1. Brazil heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                        6.5.2. Mexico
                              6.5.2.1. Mexico heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                     6.6. Middle East and Africa
                        6.6.1. South Africa
                              6.6.1.1. South Africa heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
                        6.6.2. Middle East
                              6.6.2.1. Middle East heart attack diagnostics market, by test type, 2013 - 2024 (USD Million)
Chapter 7. Competitive Landscape
                     7.1. Company Profiles
                        7.1.1. Siemens Healthcare GmbH
                              7.1.1.1. Company overview
                              7.1.1.2. Financial performance
                              7.1.1.3. Test type benchmarking
                              7.1.1.4. Strategic initiatives
                        7.1.2. Schiller AG
                              7.1.2.1. Company overview
                              7.1.2.2. Financial performance
                              7.1.2.3. Test type benchmarking
                              7.1.2.4. Strategic initiatives
                        7.1.3. GE Healthcare
                              7.1.3.1. Company overview
                              7.1.3.2. Financial performance
                              7.1.3.3. Test type benchmarking
                              7.1.3.4. Strategic initiatives
                        7.1.4. Midmark Corporation
                              7.1.4.1. Company overview
                              7.1.4.2. Financial performance
                              7.1.4.3. Test type benchmarking
                              7.1.4.4. Strategic initiatives
                        7.1.5. Koninklijke Philips N.V.
                              7.1.5.1. Company overview
                              7.1.5.2. Financial performance
                              7.1.5.3. Test type benchmarking
                              7.1.5.4. Strategic initiatives
                        7.1.6. Bionet Co., Ltd.
                              7.1.6.1. Company overview
                              7.1.6.2. Financial performance
                              7.1.6.3. Test type benchmarking
                              7.1.6.4. Strategic initiatives
                        7.1.7. Welch Allyn
                              7.1.7.1. Company overview
                              7.1.7.2. Financial performance
                              7.1.7.3. Test type benchmarking
                              7.1.7.4. Strategic initiatives
                        7.1.8. Toshiba Medical Systems Corporation
                              7.1.8.1. Company overview
                              7.1.8.2. Financial performance
                              7.1.8.3. Test type benchmarking
                              7.1.8.4. Strategic initiatives
                        7.1.9. Mortara Instrument
                              7.1.9.1. Company overview
                              7.1.9.2. Financial performance
                              7.1.9.3. Test type benchmarking
                              7.1.9.4. Strategic initiatives
                        7.1.10. Hitachi Medical systems
                              7.1.10.1. Company overview
                              7.1.10.2. Financial performance
                              7.1.10.3. Test type benchmarking
                              7.1.10.4. Strategic initiatives
                        7.1.11. Roche Diagnostics
                              7.1.11.1. Company overview
                              7.1.11.2. Financial performance
                              7.1.11.3. Test type benchmarking
                              7.1.11.4. Strategic initiatives

List of Tables

1. Heart attack diagnostics market - Industry Snapshot & Key Buying Criteria, 2013 - 2024
2. Heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
3. Heart attack diagnostics market, by region, 2013 - 2024 (USD Million)
4. Heart attack diagnostics - Key Market Driver Analysis
5. Heart attack diagnostics - Key Market Restraint Analysis
6. North America heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
7. U.S. heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
8. Canada heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
9. Europe heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
10. Germany heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
11. UK heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
12. Asia Pacific heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
13. India heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
14. China heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
15. Latin America heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
16. Brazil heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
17. Mexico heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
18. MEA heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
19. South Africa heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)
20. Middle East heart attack diagnostics market revenue, by test type, 2013 - 2024 (USD Million)

List of Figures

1. Market research process
2. Information procurement
3. Primary research pattern
4. Market research approaches
5. QFD modeling for market share assessment
6. Market summary
7. Market trends & outlook
8. Heart attack diagnostics: Market segmentation& scope
9. Heart attack diagnostics market driver relevance analysis (Current & future impact)
10. SWOT Analysis, By Factor (political & legal, economic and technological)
11. Heart attack diagnostics market: Porter’s Five Forces Analysis
12. Heart attack diagnostics market: Company Market Share Analysis, 2015
13. Key opportunities prioritized
14. Heart attack diagnostics market key takeaways
15. Heart attack diagnostics market test type outlook: Key takeaways
16. ECG heart attack diagnostics market, 2013 - 2024 (USD Million)
17. Blood tests heart attack diagnostics market, 2013 - 2024 (USD Million)
18. Others heart attack diagnostics market, 2013 - 2024 (USD Million)
19. Regional market place: Key takeaways
20. Regional outlook, 2016 & 2024